NeuCyte

Mountain View, United States

NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.

$500K raised

Aug 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NeuCyte raised?

NeuCyte has raised $500K in total funding. The most recent round was Grant. The last funding was announced in August 2023.

Who are NeuCyte's investors?

NeuCyte's investors include Leaguer Venture Capital, Cowin Venture, Wisemont Capital, National Institute of Health.

Where is NeuCyte headquartered?

NeuCyte is headquartered in Mountain View, United States.

What does NeuCyte do?

NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.

What stage is NeuCyte at?

NeuCyte is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 14, 2023.

MLA

"NeuCyte — Funding & Investors." VCBacked, August 14, 2023, https://www.vcbacked.co/company/neucyte. Accessed July 1, 2026.

APA

VCBacked. (2023). NeuCyte — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/neucyte

Wikipedia (cite web)

{{cite web |title=NeuCyte — Funding & Investors |url=https://www.vcbacked.co/company/neucyte |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 14, 2023.